Status:
COMPLETED
Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis
Lead Sponsor:
Dong-A University
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18-87 years
Phase:
PHASE1
Brief Summary
Photodynamic therapy (PDT) using methyl aminolevulinate (MAL) is an effective first-line treatment for actinic keratosis (AK). Erbium: yttrium-aluminium-garnet (Er:YAG) ablative fractional laser-assis...
Detailed Description
Photodynamic therapy (PDT) is widely used in the treatment of superficial skin cancer. It has an excellent cosmetic outcome, and it could be considered the first-line therapy for Actinic keratosis (AK...
Eligibility Criteria
Inclusion
- age \>18 years
- the presence of 2-10 facial AK lesions
Exclusion
- lactating or pregnant women
- patients with porphyria
- a known allergy to any of the constituents of the MAL cream and lidocaine
- patients with systemic disease
- history of malignant melanoma
- tendency for melasma development or keloid formation
- any AK treatment of the area in the previous 4 weeks
- any conditions associated with a risk of poor protocol compliance
- patients on immunosuppressive treatment
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT02248298
Start Date
January 1 2012
End Date
June 1 2014
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dong-A University
Busan, Dong Dae Sin-dong, Seo-gu, South Korea, 602-715